Top States
Nira+ Top StatesApr 2026
Top states where Nira+ is active based on indexed sales coverage.
Is this your Brand? Log in to Hoodie!
Nira+
Apr 2026
Overview
We develop high-quality, THC and CBD-rich products aimed at improving the quality of life for cannabis patients. With deep roots in science and medicine, we are focused on purity and consistency. Our products offer patients new options for improved wellness.
NIRA+ achieved remarkable sales growth of 91.7% YoY, elevating its rank from #6 to #2 in Virginia. Despite a 15.6% decline over the last three months, the brand's premium positioning remains strong, with a 4.1% uptick in sales recently.
Categories
ConcentratesOralTopicals
- Top Category: Concentrates
- Price Tier: Premium
- States Active: 2
Trend View
Market Insights SnapshotApr 2026
24-Month Trend
Average Price
$37.89
YoY Sales Trend
95.4%
2Y Sales Trend
235.1%
Concentrates dominate at 67.0% of total sales, surging +201.3% YoY—fastest in the market. Oral products hold 28.3% with +2.5% YoY growth, while Topicals account for 4.3%, climbing +89.9% YoY.
| Category | Sales Share | Avg Price | YoY |
|---|---|---|---|
| Concentrates | 67.8% | $37.97 | 224.4% |
| Oral | 27.9% | $39.44 | 0.9% |
| Topicals | 4.3% | $29.2 | 89.9% |
Trend View
Market Insights SnapshotApr 2026
24-Month Trend
Average Price
$37.89
YoY Sales Trend
95.4%
2Y Sales Trend
235.1%
Category Breakout
| Category | Sales Share | Avg Price | YoY |
|---|---|---|---|
| Concentrates | 67.8% | $37.97 | 224.4% |
| Oral | 27.9% | $39.44 | 0.9% |
| Topicals | 4.3% | $29.2 | 89.9% |
State Rank Table
| State | Concentrates | Oral | Topicals |
|---|---|---|---|
| Virginia | 2 | 2 | 2 |
| Pennsylvania | 23 | 13 | ⊖ |
NIRA+ has a stronghold in Virginia and Pennsylvania, with Virginia representing 77.2% of its sales. Currently active in 2 states, the brand benefits from significant geographic concentration.
| State | Concentrates | Oral | Topicals |
|---|---|---|---|
| 2 | 2 | 2 | |
| 23 | 13 | ⊖ |
Market Position
Competitive LandscapeApr 2026
NIRA+ ranks #2 in the Concentrates category, competing closely with THE LAB at #1 and AMBER at #3. Over the past year, it improved its position from #6 to #2, gaining ground on its competitors.
SKU View
Top Selling ProductsApr 2026
Top products for Apr 2026 with sales and momentum indicators.
| Product | Category | MoM |
|---|---|---|
#1  | Concentrates | 15.5% |
#2 | Concentrates | 76.0% |
#3 | Concentrates | 140.6% |
#4 ![2:1 Serene [30ml] (300mg Thc/150mg Cbn)](/_next/image?url=https%3A%2F%2Fdata-item-images.s3.us-east-2.amazonaws.com%2Fsuccess%2Fdf7ed7088165bb3b7ae8ab68ea88c241&w=64&q=75){kind=small} | Oral | 29.8% |
#5 | Concentrates | 31.4% |
#6 ![Balanced [60g] (150mg Thc/150mg Cbd)](/_next/image?url=https%3A%2F%2Fdata-item-images.s3.us-east-2.amazonaws.com%2Fsuccess%2F63cee635ab1d9c23af30f81e13894ed7&w=64&q=75){kind=small} | Topicals | 68.1% |
#7 | Concentrates | 11.7% |
Benchmarking
Competitive Peer Set
Peer brands benchmarked against Nira+ using competitive landscape rank coverage, proximity, and momentum.
